← back to search

Nianjiao Liu

Harbin Medical University · CN
Area of research
Cardiology and Cardiovascular Medicine · Oncology
Research interest
Research interests include Cancer research, Medicine, Diabetes mellitus, Intensive care medicine, Incidence (geometry), and Risk factor.
h-index
citations
30
works
3
NIH funding
primary concept
email

Recent publications

Exosomal MiR-4261 mediates calcium overload in RBCs by downregulating the expression of ATP2B4 in multiple myeloma
Frontiers in Oncology 2022cited by 5position: middledoi
Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells <i>in Vitro</i> and <i>in Vivo</i>
Biological and Pharmaceutical Bulletin 2021cited by 6position: middledoi
The relationship between diabetic risk factors, diabetic complications and salt intake
Journal of Diabetes and its Complications 2018cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hongyu Kuang · Harbin Medical University1 papers (2018–2018) · 1 papers (2022–2022) · 1 papers (2021–2021)Jie Pan · Palo Alto University1 papers (2022–2022)Daolin Cheng · Harbin Medical University1 papers (2018–2018)Xueying Sun · Medical College of Wisconsin1 papers (2021–2021)Zhuanghui Hao · Shanxi Medical University1 papers (2022–2022)Jiangxia Cui · Soochow University1 papers (2022–2022)Xingpeng Bu · Shanxi Medical University1 papers (2022–2022)Weidong Li · Univates1 papers (2021–2021)Ziyi Li · South China Agricultural University1 papers (2021–2021)Yinghua Li · Qingdao Agricultural University1 papers (2022–2022)Yuzhu Wang · South China Agricultural University1 papers (2022–2022)Lili Sun · Ministry of Education of the People's Republic of China1 papers (2022–2022) · 1 papers (2021–2021)Leilei Lin · Harbin Medical University1 papers (2022–2022)Jing Xu · Duke University1 papers (2022–2022)Shuang Han · Sichuan University1 papers (2018–2018)Zhibo Guo · Harbin Medical University1 papers (2022–2022)Sicheng Bian · Case Western Reserve University1 papers (2022–2022)